Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression (original) (raw)

• Letter
• Published: 29 November 2001
• Renhai Cao2,
• Kristian Svensson5,6,7 nAff8,
• Göran Bertilsson5,6,8 nAff7,
• Mikael Asman3 nAff6,
• Hirotoshi Tanaka4,
• Yihai Cao2,
• Anders Berkenstam5,7,8 nAff6 &
• …
• Lorenz Poellinger1

Nature volume 414, pages 550–554 (2001)Cite this article

• 3365 Accesses
• 524 Citations
• 14 Altmetric
• Metrics details

Abstract

Alteration of gene expression is a crucial component of adaptive responses to hypoxia. These responses are mediated by hypoxia-inducible transcription factors (HIFs)1,2. Here we describe an inhibitory PAS (Per/Arnt/Sim) domain protein, IPAS, which is a basic helix-loop-helix (bHLH)/PAS protein structurally related to HIFs. IPAS contains no endogenous transactivation function but demonstrates dominant negative regulation of HIF-mediated control of gene expression. Ectopic expression of IPAS in hepatoma cells selectively impairs induction of genes involved in adaptation to a hypoxic environment, notably the vascular endothelial growth factor (VEGF) gene, and results in retarded tumour growth and tumour vascular density in vivo. In mice, IPAS was predominantly expressed in Purkinje cells of the cerebellum and in corneal epithelium of the eye. Expression of IPAS in the cornea correlates with low levels of expression of the VEGF gene under hypoxic conditions. Application of an IPAS antisense oligonucleotide to the mouse cornea induced angiogenesis under normal oxygen conditions, and demonstrated hypoxia-dependent induction of VEGF gene expression in hypoxic corneal cells. These results indicate a previously unknown mechanism for negative regulation of angiogenesis and maintenance of an avascular phenotype.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

References

1. Bunn, H. F. & Poyton, R. O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76, 839–885 (1996).
   Article CAS Google Scholar
2. Wenger, R. H. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203, 1253–1263 (2000).
   CAS PubMed Google Scholar
3. Krogh, A., Brown, M., Mian, I. S., Sjolander, K. & Haussler, D. Hidden Markov models in computational biology. Applications to protein modeling. J. Mol. Biol. 235, 1501–1531 (1994).
   Article CAS Google Scholar
4. Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995).
   Article ADS CAS Google Scholar
5. Ema, M. et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl Acad. Sci. USA 94, 4273–4278 (1997).
   Article ADS CAS Google Scholar
6. Tian, H., McKnight, S. L. & Russell, D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72–82 (1997).
   Article CAS Google Scholar
7. Semenza, G. L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983–1991 (2000).
   CAS PubMed Google Scholar
8. Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y. & Poellinger, L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519–6525 (1999).
   Article CAS Google Scholar
9. Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).
   Article ADS CAS Google Scholar
10. Wiesener, M. S. et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 92, 2260–2268 (1998).
    CAS PubMed Google Scholar
11. Li, H., Ko, H. P. & Whitlock, J. P. Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1α. J. Biol. Chem. 271, 21262–21267 (1996).
    Article CAS Google Scholar
12. Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604–4613 (1996).
    Article CAS Google Scholar
13. Poellinger, L. in Inducible Gene Expression (ed. Baeuerle, P. A.) 177–205 (Birkhäuser, Boston, 1995).
    Book Google Scholar
14. Thakur, A., Willcox, M. D. & Stapleton, F. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. J. Clin. Immunol. 18, 61–70 (1998).
    Article CAS Google Scholar
15. Sack, R. A., Beaton, A. R. & Sathe, S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr. Eye Res. 18, 186–193 (1999).
    Article CAS Google Scholar
16. Gradin, K. et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16, 5221–5231 (1996).
    Article CAS Google Scholar
17. Ravi, R. et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14, 34–44 (2000).
    CAS PubMed PubMed Central Google Scholar
18. Zundel, W. et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391–396 (2000).
    CAS PubMed PubMed Central Google Scholar
19. Li, J. et al. PR 39, a peptide regulator of angiogenesis. Nature Med. 6, 49–55 (2000).
    Article CAS Google Scholar
20. Norton, J. D., Deed, R. W., Craggs, G. & Sablitzky, F. Id helix-loop-helix protein in cell growth and differentiation. Trends Cell Biol. 8, 58–65 (1998).
    CAS PubMed Google Scholar
21. Eddy, S. R. Multiple alignment using hidden Markov models. Ismb 3, 114–120 (1995).
    CAS PubMed Google Scholar
22. Tanimoto, K., Makino, Y., Pereira, T. & Poellinger, L. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19, 4298–4309 (2000).
    Article CAS Google Scholar
23. Bertilsson, G. et al. Identification of a human nuclear receptor defines a new signaling pathway for _CYP_3A induction. Proc. Natl Acad. Sci. USA 95, 12208–12213 (1998).
    Article ADS CAS Google Scholar
24. Cao, R. et al. Suppression of aniogenesis by a novel inhibitor, K1-5, generated by plasmin-mediated proteolysis. Proc. Natl Acad. Sci. USA 96, 5728–5733 (1999).
    Article ADS CAS Google Scholar

Download references

Acknowledgements

We thank Y. Fujii-Kuriyama and I. Pongratz for reagents. This work was supported by grants from the Swedish Medical Research Council, Pharmacia Corporation, Swedish Cancer Society, the Human Frontiers Science Program, the Uehara Memorial Foundation, and the Japanese Ministry of Education, Culture, Sports, Science and Technology.

Author information

Author notes

1. Mikael Asman & Anders Berkenstam
   Present address: Karobia AB, S-141 57, Huddinge, Sweden
2. Göran Bertilsson
   Present address: Neuronova AB, S-114 33, Stockholm, Sweden
3. Kristian Svensson
   Present address: Leica Microsystems AB, S-191 27, Solléntuna, Sweden

Authors and Affiliations

1. Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, S-171 77, Sweden
   Yuichi Makino & Lorenz Poellinger
2. Department of Microbiology and Tumor Biology, Karolinska Institutet, Stockholm, S-171 77, Sweden
   Renhai Cao & Yihai Cao
3. Center for Genomics and Bioinformatics, Karolinska Institutet, Stockholm, S-171 77, Sweden
   Mikael Asman
4. Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan
   Yuichi Makino & Hirotoshi Tanaka
5. Pharmacia Corporation, Stockholm, S-112 87, Sweden
   Kristian Svensson, Göran Bertilsson & Anders Berkenstam
6. Karobia AB, S-141 57, Huddinge, Sweden
   Kristian Svensson & Göran Bertilsson
7. Neuronova AB, S-114 33, Stockholm, Sweden
   Kristian Svensson & Anders Berkenstam
8. Leica Microsystems AB, S-191 27, Solléntuna, Sweden
   Göran Bertilsson & Anders Berkenstam

Authors

1. Yuichi Makino
   You can also search for this author inPubMed Google Scholar
2. Renhai Cao
   You can also search for this author inPubMed Google Scholar
3. Kristian Svensson
   You can also search for this author inPubMed Google Scholar
4. Göran Bertilsson
   You can also search for this author inPubMed Google Scholar
5. Mikael Asman
   You can also search for this author inPubMed Google Scholar
6. Hirotoshi Tanaka
   You can also search for this author inPubMed Google Scholar
7. Yihai Cao
   You can also search for this author inPubMed Google Scholar
8. Anders Berkenstam
   You can also search for this author inPubMed Google Scholar
9. Lorenz Poellinger
   You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toLorenz Poellinger.

Rights and permissions

About this article

Cite this article

Makino, Y., Cao, R., Svensson, K. et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.Nature 414, 550–554 (2001). https://doi.org/10.1038/35107085

Download citation

• Received: 16 May 2001
• Accepted: 04 October 2001
• Issue Date: 29 November 2001
• DOI: https://doi.org/10.1038/35107085